Spots Global Cancer Trial Database for gastric carcinoma
Every month we try and update this database with for gastric carcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Clinical Study of Nab-paclitaxel Combined With Toripalimab in Local Advanced or Metastatic G/GEJ Carcinoma | NCT04443036 | Gastric Carcino... | Albumin-Bound P... Toripalimab | 18 Years - 70 Years | China Medical University, China | |
| A Study of Apatinib Versus Docetaxol Patients With Advanced Gastric Cancer | NCT02409199 | Gastric Carcino... | Docetaxel apatinib | 18 Years - | Shanghai Zhongshan Hospital | |
| DNA Methylation Biomarkers and Metastasis of Gastric Carcinoma | NCT02159339 | Gastric Carcino... | - | Peking University Cancer Hospital & Institute | ||
| Early Detection and Screening Strategy of Gatric Cancer in Sichuan Province-A Prospective Cohort Study (WCH-GC-SIGES-01) | NCT03597672 | Neoplasm, Stoma... H. Pylori Infec... Chronic Atrophi... | 20 Years - 70 Years | West China Hospital | ||
| CAR-pNK Cell Immunotherapy in MUC1 Positive Relapsed or Refractory Solid Tumor | NCT02839954 | Hepatocellular ... Non-small Cell ... Pancreatic Carc... Triple-Negative... Malignant Gliom... Colorectal Carc... Gastric Carcino... | anti-MUC1 CAR-p... | 18 Years - | PersonGen BioTherapeutics (Suzhou) Co., Ltd. | |
| Capecitabine/Tesetaxel Versus Capecitabine/Placebo as Second-line Therapy for Gastric Cancer | NCT01573468 | Gastric Carcino... | Tesetaxel Placebo Capecitabine | 18 Years - | Genta Incorporated | |
| Tesetaxel Plus Capecitabine and Cisplatin in Advanced Gastric Cancer | NCT01348009 | Gastric Carcino... | Tesetaxel-capec... | 20 Years - | Genta Incorporated | |
| Study of Pembrolizumab (MK-3475) as First-Line Monotherapy and Combination Therapy for Treatment of Advanced Gastric or Gastroesophageal Junction Adenocarcinoma (MK-3475-062/KEYNOTE-062) | NCT02494583 | Gastric Adenoca... | Pembrolizumab Cisplatin 5-FU Capecitabine Placebo | 18 Years - | Merck Sharp & Dohme LLC | |
| Pharmacokinetic Study of Lurbinectedin in Combination With Irinotecan in Patients With Selected Solid Tumors | NCT02611024 | Advanced Solid ... Glioblastoma Soft Tissue Sar... Endometrial Car... Epithelial Ovar... Mesothelioma Gastroenteropan... SCLC Gastric Carcino... Pancreatic Aden... Colorectal Carc... Neuroendocrine ... | Lurbinectedin Irinotecan | 18 Years - | PharmaMar | |
| Apatinib Versus Placebo as a Third Line Treatment in Patients With Advanced or Metastatic Gastric Cancer | NCT00970138 | Gastric Carcino... | apatinib tablet | 18 Years - 70 Years | Fudan University | |
| A Safety Study of SEA-TGT (SGN-TGT) in Advanced Cancer | NCT04254107 | Non-small Cell ... Gastric Carcino... Gastroesophagea... Classical Hodgk... Diffuse Large B... Peripheral T-ce... Cutaneous Melan... Head and Neck S... Bladder Cancer Ovarian Cancer Triple Negative... Cervical Cancer | SEA-TGT sasanlimab brentuximab ved... | 18 Years - | Seagen Inc. | |
| Anxiety Before Non-cardiac Surgery in Adults | NCT05596188 | Myoma of Uterus Colon Cancer Gastric Carcino... Prostate Cancer Femoral Head Ne... | 18 Years - 80 Years | RenJi Hospital | ||
| Educational Brochure in Preparing Patients With Gastric Cancer and Their Caregivers for Recovery After Surgery | NCT02334332 | Anxiety Gastric Carcino... Stress | Educational Int... Standard Follow... Quality-of-Life... | 21 Years - | City of Hope Medical Center | |
| Intravital Microscopy in Human Solid Tumors | NCT03823144 | Solid Tumor, Ad... Clinical Stage ... Gastric Carcino... Malignant Solid... Metastatic Colo... Metastatic Gast... Metastatic Prim... Metastatic Sarc... Postneoadjuvant... Resectable Colo... Resectable Live... Resectable Panc... Resectable Sarc... Stage IV Colore... | Diagnostic Micr... Fluorescein Sod... | 18 Years - | Mayo Clinic | |
| XELOX Combined With Apatinib as Post-operative Chemotherapy in Locally Advanced Gastric Adenocarcinoma | NCT03599778 | Gastric Carcino... | Apatinib | 18 Years - 70 Years | Anhui Provincial Hospital | |
| Effects on Quality of Life With Zinc Supplementation in Patients With Gastrointestinal Cancer | NCT03819088 | Gastric Carcino... Liver and Intra... Unresectable Es... Unresectable Pa... | Zinc | - | Emory University | |
| DNA Methylation Biomarkers and Metastasis of Gastric Carcinoma | NCT02159339 | Gastric Carcino... | - | Peking University Cancer Hospital & Institute | ||
| Intravital Microscopy in Human Solid Tumors | NCT03823144 | Solid Tumor, Ad... Clinical Stage ... Gastric Carcino... Malignant Solid... Metastatic Colo... Metastatic Gast... Metastatic Prim... Metastatic Sarc... Postneoadjuvant... Resectable Colo... Resectable Live... Resectable Panc... Resectable Sarc... Stage IV Colore... | Diagnostic Micr... Fluorescein Sod... | 18 Years - | Mayo Clinic | |
| Safety, Tolerability and Pharmacokinetics of an Anti-PD-1 Monoclonal Antibody in Subjects With Advanced Malignancies | NCT03474640 | Advanced Malign... | Toripalimab, Re... | 18 Years - | Shanghai Junshi Bioscience Co., Ltd. | |
| Apatinib Versus Placebo as a Third Line Treatment in Patients With Advanced or Metastatic Gastric Cancer | NCT00970138 | Gastric Carcino... | apatinib tablet | 18 Years - 70 Years | Fudan University | |
| Safety, Tolerability and Pharmacokinetics of an Anti-PD-1 Monoclonal Antibody in Subjects With Advanced Malignancies | NCT03474640 | Advanced Malign... | Toripalimab, Re... | 18 Years - | Shanghai Junshi Bioscience Co., Ltd. | |
| Intraperitoneal Infusion of EpCAM CAR-T Cell in Advanced Gastric Cancer With Peritoneal Metastasis (WCH-GC-CART) | NCT03563326 | Neoplasm, Stoma... Metastases, Neo... Neoplasm Seedin... | CAR-T cells tar... Chemotherapy | 18 Years - 75 Years | West China Hospital | |
| Dose Escalation Study of Liposomal Paclitaxel With/Without Capecitabine in Patients With Advanced Gastric Carcinoma | NCT00639522 | Gastric Carcino... | Liposomal pacli... | 18 Years - 65 Years | Nanjing Sike Pharmaceutical Co., Ltd. | |
| Telehealth for the Self-Management of Dietary Quality of Life in Patients After Stomach Cancer Surgery | NCT05203627 | Gastric Carcino... Gastroesophagea... | Best Practice Questionnaire A... Telemedicine Vi... | 21 Years - | City of Hope Medical Center | |
| A Study Evaluating MM-310 in Patients With Solid Tumors | NCT03076372 | Solid Tumors Urothelial Carc... Gastric Carcino... Squamous Cell C... Ovarian Cancer Pancreatic Duct... Prostate Adenoc... Non-small Cell ... Small Cell Lung... Triple Negative... Endometrial Car... Soft Tissue Sar... | MM-310 | 18 Years - | Merrimack Pharmaceuticals | |
| XELOX Plus Apatinib vs XELOX as Post-operative Chemotherapy in Locally Advanced Gastric Signet Ring Carcinoma | NCT03355612 | Gastric Carcino... | Apatinib XELOX | 18 Years - 70 Years | Tianjin Medical University Cancer Institute and Hospital | |
| CAR-pNK Cell Immunotherapy in MUC1 Positive Relapsed or Refractory Solid Tumor | NCT02839954 | Hepatocellular ... Non-small Cell ... Pancreatic Carc... Triple-Negative... Malignant Gliom... Colorectal Carc... Gastric Carcino... | anti-MUC1 CAR-p... | 18 Years - | PersonGen BioTherapeutics (Suzhou) Co., Ltd. | |
| Dose Escalation Study of Liposomal Paclitaxel With/Without Capecitabine in Patients With Advanced Gastric Carcinoma | NCT00639522 | Gastric Carcino... | Liposomal pacli... | 18 Years - 65 Years | Nanjing Sike Pharmaceutical Co., Ltd. | |
| A Safety Study of SGN-CD47M in Patients With Solid Tumors | NCT03957096 | Soft Tissue Sar... Colorectal Canc... Head and Neck S... Non-small Cell ... Breast Carcinom... Ovarian Carcino... Exocrine Pancre... Gastric Carcino... Melanoma | SGN-CD47M | 18 Years - | Seagen Inc. | |
| Clinical Trial of Yiqi Wenyang Jiedu Prescription in the Prevention and Treatment of Postoperative Metastasis and Recurrence of Gastric Cancer | NCT05229809 | Gastric Carcino... | Yiqi Wenyang Ji... Simulation agen... | 18 Years - 75 Years | Guang'anmen Hospital of China Academy of Chinese Medical Sciences | |
| Risk Assessment Evaluation for Identifying Participants at High Risk for Stomach Cancer | NCT06408220 | Gastric Carcino... | Biopsy Biospecimen Col... Breath Test Esophagogastrod... Questionnaire A... | 40 Years - 80 Years | City of Hope Medical Center | |
| Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) | NCT02465060 | Advanced Lympho... Advanced Malign... Bladder Carcino... Breast Carcinom... Cervical Carcin... Colon Carcinoma Colorectal Carc... Endometrial Car... Esophageal Carc... Gastric Carcino... Glioma Head and Neck C... Hematopoietic a... Kidney Carcinom... Liver Carcinoma Lung Carcinoma Lymphoma Malignant Uteri... Melanoma Multiple Myelom... Ovarian Carcino... Pancreatic Carc... Prostate Carcin... Rectal Carcinom... Recurrent Bladd... Recurrent Breas... Recurrent Cervi... Recurrent Colon... Recurrent Color... Recurrent Esoph... Recurrent Gastr... Recurrent Gliom... Recurrent Head ... Recurrent Liver... Recurrent Lung ... Recurrent Lymph... Recurrent Malig... Recurrent Melan... Recurrent Multi... Recurrent Ovari... Recurrent Pancr... Recurrent Prost... Recurrent Recta... Recurrent Skin ... Recurrent Thyro... Recurrent Uteri... Refractory Lymp... Refractory Mali... Refractory Mult... Skin Carcinoma Thyroid Gland C... Uterine Corpus ... | Adavosertib Afatinib Afatinib Dimale... Binimetinib Biopsy Biospecimen Col... Capivasertib Computed Tomogr... Copanlisib Copanlisib Hydr... Crizotinib Cytology Specim... Dabrafenib Dabrafenib Mesy... Dasatinib Defactinib Defactinib Hydr... Echocardiograph... Erdafitinib Fexagratinib Ipatasertib Laboratory Biom... Larotrectinib Larotrectinib S... Magnetic Resona... Multigated Acqu... Nivolumab Osimertinib Palbociclib Pertuzumab PI3K-beta Inhib... Radiologic Exam... Radionuclide Im... Relatlimab Sapanisertib Sunitinib Malat... Taselisib Trametinib Trastuzumab Trastuzumab Emt... Ulixertinib Vismodegib | 18 Years - | National Cancer Institute (NCI) | |
| The RIOT Trial: Re-Defining Frailty and Improving Outcomes With Prehabilitation for Pancreatic, Liver, or Gastric Cancer | NCT04602026 | Adult Liver Car... Gastric Carcino... Malignant Solid... Pancreatic Carc... | Best Practice Exercise Interv... Physical Therap... Questionnaire A... | 18 Years - | Ohio State University Comprehensive Cancer Center | |
| Apatinib Versus Placebo as a Third Line Treatment in Patients With Advanced or Metastatic Gastric Cancer | NCT00970138 | Gastric Carcino... | apatinib tablet | 18 Years - 70 Years | Fudan University | |
| DNA Methylation Biomarkers and Metastasis of Gastric Carcinoma | NCT02159339 | Gastric Carcino... | - | Peking University Cancer Hospital & Institute | ||
| Dose Escalation Study of Liposomal Paclitaxel With/Without Capecitabine in Patients With Advanced Gastric Carcinoma | NCT00639522 | Gastric Carcino... | Liposomal pacli... | 18 Years - 65 Years | Nanjing Sike Pharmaceutical Co., Ltd. | |
| A Safety Study of SGN-CD47M in Patients With Solid Tumors | NCT03957096 | Soft Tissue Sar... Colorectal Canc... Head and Neck S... Non-small Cell ... Breast Carcinom... Ovarian Carcino... Exocrine Pancre... Gastric Carcino... Melanoma | SGN-CD47M | 18 Years - | Seagen Inc. | |
| A Registry Study on Shenqifuzheng（a Chinese Medicine Injection）Used in Hospitals in China | NCT01812876 | Gastric Carcino... Carcinoma of th... | 18 Years - | China Academy of Chinese Medical Sciences | ||
| Psychological, Psychophysical and Epigenetic Determinants of Chronic Pain After Cytoreductive - Hyperthermic Intraoperative Chemotherapy | NCT05083338 | Appendix Carcin... Carcinomatosis Colorectal Carc... Gastric Carcino... Malignant Perit... Malignant Solid... | Biospecimen Col... Pain Assessment Questionnaire A... | 18 Years - | M.D. Anderson Cancer Center | |
| Early Detection and Screening Strategy of Gatric Cancer in Sichuan Province-A Prospective Cohort Study (WCH-GC-SIGES-01) | NCT03597672 | Neoplasm, Stoma... H. Pylori Infec... Chronic Atrophi... | 20 Years - 70 Years | West China Hospital | ||
| A Real World Study of Apatinib in Treatment of Patients With Gastric Carcinoma | NCT03735511 | Gastric Carcino... | 18 Years - | Henan Cancer Hospital | ||
| Psychological, Psychophysical and Epigenetic Determinants of Chronic Pain After Cytoreductive - Hyperthermic Intraoperative Chemotherapy | NCT05083338 | Appendix Carcin... Carcinomatosis Colorectal Carc... Gastric Carcino... Malignant Perit... Malignant Solid... | Biospecimen Col... Pain Assessment Questionnaire A... | 18 Years - | M.D. Anderson Cancer Center | |
| A Study Evaluating MM-310 in Patients With Solid Tumors | NCT03076372 | Solid Tumors Urothelial Carc... Gastric Carcino... Squamous Cell C... Ovarian Cancer Pancreatic Duct... Prostate Adenoc... Non-small Cell ... Small Cell Lung... Triple Negative... Endometrial Car... Soft Tissue Sar... | MM-310 | 18 Years - | Merrimack Pharmaceuticals | |
| Experimental PET Imaging Scans Before Cancer Surgery to Study the Amount of PET Tracer Accumulated in Normal and Cancer Tissues | NCT04147494 | Breast Carcinom... Colon Carcinoma Esophageal Carc... Gastric Carcino... Head and Neck C... Kidney Carcinom... Lung Carcinoma Ovarian Carcino... Pancreatic Carc... Solid Neoplasm Uterine Corpus ... | Computed Tomogr... Gallium Ga 68 F... Gallium Ga 68-l... Positron Emissi... 18F-FDG | 18 Years - | Jonsson Comprehensive Cancer Center | |
| Confocal Laser Endomicroscopy for the Diagnosis of Gastric Intestinal Metaplasia, Intraepithelial Neoplasia, and Carcinoma | NCT01642797 | Gastric Intesti... Gastric Intraep... Gastric Carcino... | Confocal laser ... Standard White-... | 18 Years - 80 Years | Shandong University | |
| Pilot Study on Intra-abdominal Photodynamic Diagnosis in Peritoneal Carcinosis | NCT02840331 | Peritoneal Carc... | St. John's Wort Photodynamic di... | 18 Years - | University Hospital Tuebingen | |
| Risk Assessment Evaluation for Identifying Participants at High Risk for Stomach Cancer | NCT06408220 | Gastric Carcino... | Biopsy Biospecimen Col... Breath Test Esophagogastrod... Questionnaire A... | 40 Years - 80 Years | City of Hope Medical Center | |
| Oral Cryotherapy Plus Acupressure and Acupuncture Versus Oral Cryotherapy for Decreasing Chemotherapy-Induced Peripheral Neuropathy From Oxaliplatin-Based Chemotherapy in Patients With Gastrointestinal Cancer | NCT04505553 | Appendix Carcin... Colon Carcinoma Esophageal Carc... Gastric Carcino... Liver and Intra... Malignant Diges... Pancreatic Carc... Rectal Carcinom... Small Intestina... Anal Carcinoma Digestive Syste... Digestive Syste... Pancreatic Neur... | Acupuncture The... Acupressure The... Oral Cryotherap... Questionnaire A... Quality-of-Life... | 18 Years - | University of Washington | |
| Clinical Study of Nab-paclitaxel Combined With Toripalimab in Local Advanced or Metastatic G/GEJ Carcinoma | NCT04443036 | Gastric Carcino... | Albumin-Bound P... Toripalimab | 18 Years - 70 Years | China Medical University, China | |
| Immunotherapy of Gastric Cancer With Autologous Tumor Derived Heat Shock Protein gp96 | NCT02317471 | Gastric Carcino... | autologous gp96... Oxaliplatin+S-1 | 18 Years - 75 Years | Chinese PLA General Hospital | |
| Immunohistochemical Evaluation of DNA Methylation and Histone Modification in H. Pylori Associated Gastric Carcinoma | NCT05811546 | Gastric Carcino... | Immunohistochem... | 30 Years - 100 Years | Assiut University | |
| Telehealth for the Self-Management of Dietary Quality of Life in Patients After Stomach Cancer Surgery | NCT05203627 | Gastric Carcino... Gastroesophagea... | Best Practice Questionnaire A... Telemedicine Vi... | 21 Years - | City of Hope Medical Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
